NCCN Guidelines Insights: Kidney Cancer, Version 2.2020
2019; National Comprehensive Cancer; Volume: 17; Issue: 11 Linguagem: Inglês
10.6004/jnccn.2019.0054
ISSN1540-1413
AutoresRobert J. Motzer, Eric Jonasch, M. Dror Michaelson, Lakshminarayanan Nandagopal, John L. Gore, Saby George, Ajjai Alva, Naomi B. Haas, Michael R. Harrison, Elizabeth R. Plimack, Jeffrey A. Sosman, Neeraj Agarwal, Sam B. Bhayani, Toni K. Choueiri, Brian A. Costello, Ithaar Derweesh, Thomas H. Gallagher, Steven Hancock, Christos E. Kyriakopoulos, Chad A. LaGrange, Elaine T. Lam, Clayton Lau, Bryan Lewis, Brandon J. Manley, Brittany McCreery, Andrew McDonald, Amir Mortazavi, Phillip M. Pierorazio, Lee Ponsky, Bruce G. Redman, Bradley G. Somer, Geoffrey Wile, Mary A. Dwyer, Lydia J. Hammond, Griselda Zuccarino-Catania,
Tópico(s)Pancreatic and Hepatic Oncology Research
ResumoThe NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non–clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.
Referência(s)